Loading...

Aprea Therapeutics ($APRE)

APRE Overview

Aprea Therapeutics, a biopharmaceutical company, develops and commercializes cancer therapeutics that reactivate mutant p53 tumor suppressor protein.Its lead product candidate is APR-246, a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes and acute myeloid leukemia.The company was founded in 2006 and is headquartered in Boston, Massachusetts. (From: StockAnalysis.com)

MORE ABOUT Aprea Therapeutics

Stay up to date with the best of Bullish each week.

BULLISH WEEKLY

Stay up to date with the best of Bullish each week.